Kiniksa Pharmaceuticals International (KNSA) Revenue (2017 - 2026)
Kiniksa Pharmaceuticals International (KNSA) revenue from Jun 30, 2017 to Mar 31, 2026. The TTM Kiniksa Pharmaceuticals International (KNSA) revenue is $754M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Kiniksa Pharmaceuticals International (KNSA) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +56.71% |
| 3 Years TTM | +47.22% |
Annual Revenue change of Kiniksa Pharmaceuticals International (KNSA)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $214M | -68.38% |
| 2025 | $678M | +60.09% |
| 2024 | $423M | +56.60% |
| 2023 | $270M | +22.75% |
| 2022 | $220M | +471.30% |
| 2021 | $39M | N/A |
| 2020 | $0 | N/A |
| 2019 | $0 | N/A |
| 2018 | $0 | N/A |
| 2017 | $0 | N/A |